Codiak BioSciences, Inc. Sublease Income
Codiak BioSciences, Inc. reported Sublease Income of $430.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SubleaseIncome · last filed 2022-11-03
- Codiak BioSciences, Inc. sublease income for the quarter ending 2022-09-30 was $430.00K, a 11.16% decline year-over-year.
- Codiak BioSciences, Inc. sublease income for the quarter ending 2022-06-30 was $850.00K, a 144.25% increase year-over-year.
- Codiak BioSciences, Inc. sublease income for the quarter ending 2022-03-31 was $822.00K, a 130.25% increase year-over-year.
- Codiak BioSciences, Inc. sublease income for the quarter ending 2021-12-31 was $662.00K, a 80.87% increase year-over-year.
- Codiak BioSciences, Inc. sublease income for fiscal 2021 was $1.85M, a 114.87% increase from fiscal 2020.
- Codiak BioSciences, Inc. sublease income for fiscal 2020 was $861.00K.
| Period end | Sublease Income 3 month | Sublease Income 6 month | Sublease Income 9 month | Sublease Income 12 month |
|---|---|---|---|---|
| 2022-09-30 | $430.00K 10-Q · filed 2022-11-03 | $1.28M derived: sum of 2 quarters · filed 2022-11-03 | $2.10M 10-Q · filed 2022-11-03 | $2.76M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $850.00K 10-Q · filed 2022-08-04 | $1.67M 10-Q · filed 2022-08-04 | $2.33M derived: sum of 3 quarters · filed 2022-08-04 | $2.82M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $822.00K 10-Q · filed 2022-05-05 | $1.48M derived: sum of 2 quarters · filed 2022-05-05 | $1.97M derived: sum of 3 quarters · filed 2022-11-03 | $2.32M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.15M derived: sum of 2 quarters · filed 2022-11-03 | $1.49M derived: sum of 3 quarters · filed 2022-11-03 | $1.85M 10-K · filed 2022-03-10 |
| 2021-09-30 | $484.00K 10-Q · filed 2022-11-03 | $832.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.19M 10-Q · filed 2022-11-03 | $1.55M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $348.00K 10-Q · filed 2022-08-04 | $704.00K 10-Q · filed 2022-08-04 | $1.07M derived: sum of 3 quarters · filed 2022-08-04 | $1.41M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $357.00K 10-Q · filed 2022-05-05 | $723.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.06M derived: sum of 3 quarters · filed 2022-05-05 | $1.22M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $703.00K derived: sum of 2 quarters · filed 2022-03-10 | $861.00K derived: sum of 3 quarters · filed 2022-03-10 | $861.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $337.00K 10-Q · filed 2021-11-04 | $495.00K derived: sum of 2 quarters · filed 2021-11-04 | $495.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $158.00K 10-Q · filed 2021-08-05 | $158.00K 10-Q · filed 2021-08-05 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-19 | $0.00 10-Q · filed 2020-11-19 |